Business · 1 sources covering this

Dr Reddy's gets DCGI nod for cancer drug's second indication in India

The approval allows toripalimab with cisplatin and paclitaxel as first-line treatment for unresectable advanced, recurrent or metastatic ESCC in adults

Share:WhatsApp X Reddit Facebook LinkedIn

Coverage spectrum

0 L · 1 C · 0 R

How 1 sources are covering this

Business StandardCenter·1h ago
Dr Reddy's gets DCGI nod for cancer drug's second indication in India
The approval allows toripalimab with cisplatin and paclitaxel as first-line treatment for unresectable advanced, recurrent or metastatic ESCC in adults
Read at Business Standard →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://hindustansphere.com/embed/cluster/299b3dfd224c7f36495e6cff438957c79691bc91"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="Dr Reddy's gets DCGI nod for cancer drug's second indication in India"></iframe>

Dr Reddy's gets DCGI nod for cancer drug's second indication in India

How 1 sources are covering this

Dr Reddy's gets DCGI nod for cancer drug's second indication in India

More from Business

Real Madrid Vs RB Leipzig Live Streaming: Likely Lineups; How To Watch Champions League Match?

GRAP-1 curbs imposed in Delhi-NCR as air quality deteriorates to ‘poor’

Jio IPO sets new records: Bids cross Rs 50,000 crore after full subscription in 100 minutes

Hero Motors, SML Mahindra, Wheels India locked at 10% lower circuits

Reader

Trust & legal

Across the network